| Biological Information | |
|---|---|
| Background Information: | KAT2A, also known as GCN5L2 (general control of amino acid synthesis protein 5-like 2), is an epigenetic protein that functions as a histone acetyltransferase (HAT). It is responsible for adding acetyl groups to specific lysine residues on histones, leading to the formation of euchromatin and activation of gene expression.
KAT2A is widely expressed in many tissues and is important for normal development and cellular function. It is involved in various biological processes, including transcriptional regulation, DNA damage response, and cell cycle progression.
Aberrant KAT2A activity has been implicated in various diseases, including cancer, neurological disorders, and cardiovascular diseases. KAT2A inhibitors are being developed for therapeutic purposes, and understanding its function is important for developing new therapies. |
| Target Class: | Epigenetic Protein |
| Accession Number: | Refer to CoA for Accession Number |
| Target Name: | KAT2A (GCN5L2) |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 1 year at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
KAT2A (GCN5L2)
Recombinant human KAT2A (GCN5L2) amino acids 497-662.
Datasheets
EPI024 Datasheet
View Document